Knees was Zimmer Biomet Holdings’s largest product and service line in fiscal 2025, bringing in $3.32B of $8.23B (40%).
| Product and Service | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knees | $2.78B | $3.04B | $3.17B | $3.32B | |||||||||||||
| Hips | $1.89B | $1.97B | $2.00B | $2.09B | |||||||||||||
| S.E.T | $1.70B | $1.75B | $1.87B | $2.15B | |||||||||||||
| Dental, Spine Cmft | — | — | — | — | |||||||||||||
| Spine Dental | — | — | — | — | |||||||||||||
| Spine & Cmf | — | — | — | — | |||||||||||||
| Technology Data, Bone Cement & Surgical | $570.00M | $636.00M | $640.30M | $665.60M | |||||||||||||
| Other | — | — | — | — | |||||||||||||
| Dental | — | — | — | — | |||||||||||||
| Surgical & Other | — | — | — | — | |||||||||||||
| Trauma | — | — | — | — | |||||||||||||
| Spine | — | — | — | — | |||||||||||||
| Extremities | — | — | — | — | |||||||||||||
| Total | $6.94B | $7.39B | $7.68B | $8.23B |
Zimmer Biomet Holdings brought in $8.23B from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 7.2% from $7.68B in fiscal 2024. Knees was the largest at $3.32B (40.4%), ahead of S.E.T at $2.15B (26.1%) and Hips at $2.09B (25.4%). The remaining line, Technology Data, Bone Cement & Surgical, brought in $665.60M.
Compared with fiscal 2024, S.E.T grew fastest, up 15.2% to $2.15B. Every line above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these lines grew from $6.94B to $8.23B, a compound annual growth rate of 5.9%. Knees' share held steady at about 40.4%.
Americas was Zimmer Biomet Holdings’s largest region in fiscal 2025, bringing in $5.14B of $8.23B (62%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas & Global Businesses | — | — | — | — | |||||||||||||
| Americas | $4.30B | $4.62B | $4.79B | $5.14B | |||||||||||||
| Americas Orthopedics | — | — | — | — | |||||||||||||
| Salesrevenuegoodsnet | — | — | — | — | |||||||||||||
| Emea | $1.46B | $1.59B | $1.69B | $1.83B | |||||||||||||
| Immaterial Product Category Operating Segments | — | — | — | — | |||||||||||||
| Asia Pacific | $1.19B | $1.18B | $1.19B | $1.26B | |||||||||||||
| Europe | — | — | — | — | |||||||||||||
| Americas Spine & Global Dental | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group Three | — | — | — | — | |||||||||||||
| Total | $6.94B | $7.39B | $7.68B | $8.23B |
Zimmer Biomet Holdings brought in $8.23B from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 7.2% from $7.68B in fiscal 2024. Americas was the largest at $5.14B (62.5%), ahead of Emea at $1.83B (22.2%) and Asia Pacific at $1.26B (15.3%).
Compared with fiscal 2024, Emea grew fastest, up 8.1% to $1.83B. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $6.94B to $8.23B, a compound annual growth rate of 5.9%. Americas' share of the total rose from 61.9% to 62.5%.
As Previously Reported was Zimmer Biomet Holdings’s largest revenue line in fiscal 2016, bringing in $7.68B of $7.67B (100%).
| Initial Application Period Cumulative Effect Transition | FY 2016 |
|---|---|
| As Previously Reported | $7.68B |
| New Revenue Standard Adjustment | -$15.50M |
| Total | $7.67B |
Zimmer Biomet Holdings brought in $7.67B from its two revenue lines in fiscal 2016, the year ended December 31, 2016. As Previously Reported was the largest at $7.68B (100.2%).
The total is net of New Revenue Standard Adjustment, which took $15.50M off revenue in fiscal 2016.
Zimmer Biomet Holdings (ZBH) reports its revenue by product and service, by geography and by initial application period cumulative effect transition. In fiscal 2025, Knees was its largest product and service line, bringing in $3.32B (40.4% of the total), followed by S.E.T at $2.15B (26.1%).
Knees was Zimmer Biomet Holdings' largest product and service line in fiscal 2025, bringing in $3.32B, or 40.4% of the $8.23B total across its four product and service lines.
Americas was Zimmer Biomet Holdings' largest region in fiscal 2025, bringing in $5.14B, or 62.5% of the $8.23B total across its three regions.
As Previously Reported was Zimmer Biomet Holdings' largest revenue line in fiscal 2016, bringing in $7.68B, or 100.2% of the $7.67B total across its two revenue lines.
Among Zimmer Biomet Holdings' product and service lines that make up at least 2% of revenue, S.E.T grew fastest in fiscal 2025, up 15.2% from $1.87B to $2.15B.
Every figure comes from Zimmer Biomet Holdings' annual financial filings, as reported. Each line keeps the name Zimmer Biomet Holdings gives it, and years follow its fiscal calendar.
Zimmer Biomet Holdings' revenue by product and service goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.